RFA-CA-19-025 - Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Availability of Funds for Revision Applications for Research Centers with a Focus in Chronic Disease and the Reduction of Health Disparities (P50, P30, U54) | NOT-OD-19-070 | NIH | Feb 11, 2019 | Mar 29, 2019 | P30, P50, U54 |
For technical issues E-mail OER Webmaster